Vontobel Holding Portfolio holdings
AUM
$30.4B
This Quarter Return
+12.17%
1 Year Return
+19.34%
3 Year Return
+89.17%
5 Year Return
–
10 Year Return
–
AUM
$30.4B
AUM Growth
+$30.4B
(+11%)
Cap. Flow
+$409M
Cap. Flow
% of AUM
1.34%
Top 10 Holdings %
Top 10 Hldgs %
31.28%
Holding
1,168
New
81
Increased
365
Reduced
563
Closed
65
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$754M |
| 2 |
AMRZ
Amrize Ltd
AMRZ
|
$421M |
| 3 |
Ecolab
ECL
|
$299M |
| 4 |
iShares MSCI India ETF
INDA
|
$148M |
| 5 |
Aon
AON
|
$121M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$333M |
| 2 |
Amazon
AMZN
|
$226M |
| 3 |
PepsiCo
PEP
|
$224M |
| 4 |
Mastercard
MA
|
$149M |
| 5 |
Keysight
KEYS
|
$120M |
Sector Composition
| 1 | Technology | 27.47% |
| 2 | Financials | 13.58% |
| 3 | Healthcare | 12.03% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Perspective Therapeutics
CATX
$250M
| $68.8K | ﹤0.01% |
20,000
| – | – |
|
1077
Emerald Holding
EEX
$1.03B
| $61.1K | ﹤0.01% |
+12,600
| New | +$61.1K |
|
|
BZAI
1078
Blaize Holdings, Inc. Common Stock
BZAI
$347M
| $60.4K | ﹤0.01% |
+20,271
| New | +$60.4K |
|
1079
Recursion Pharmaceuticals
RXRX
$2.01B
| $59.7K | ﹤0.01% |
11,800
| – | – |
|
1080
Immatics
IMTX
$661M
| $59.2K | ﹤0.01% |
+11,000
| New | +$59.2K |
|
1081
Myomo
MYO
$38.9M
| $58.8K | ﹤0.01% |
27,219
| – | – |
|
1082
GoodRx Holdings
GDRX
$1.49B
| $58.3K | ﹤0.01% |
+11,716
| New | +$58.3K |
|
|
BLDP
1083
Ballard Power Systems
BLDP
$580M
| $57.8K | ﹤0.01% |
36,097
| – | – |
|
1084
Repare Therapeutics
RPTX
$73.5M
| $55.6K | ﹤0.01% |
40,000
| – | – |
|
1085
3D Systems Corporation
DDD
$265M
| $53.5K | ﹤0.01% |
34,750
| – | – |
|
1086
Alector
ALEC
$272M
| $53.2K | ﹤0.01% |
38,000
+8,000
| +27% | +$11.2K |
|
1087
Adicet Bio
ACET
$61.6M
| $48.8K | ﹤0.01% |
80,000
+20,000
| +33% | +$12.2K |
|
|
BIOA
1088
BioAge Labs, Inc. Common Stock
BIOA
$169M
| $45.4K | ﹤0.01% |
11,000
| – | – |
|
1089
Werewolf Therapeutics
HOWL
$60.4M
| $43.6K | ﹤0.01% |
40,000
+5,000
| +14% | +$5.45K |
|
1090
Actinium Pharmaceuticals
ATNM
$54M
| $42K | ﹤0.01% |
30,000
| – | – |
|
1091
Direxion Daily Small Cap Bull 3x Shares
TNA
$2.12B
| $40.2K | ﹤0.01% |
+1,200
| New | +$40.2K |
|
1092
Sangamo Therapeutics
SGMO
$163M
| $39.7K | ﹤0.01% |
73,300
+15,000
| +26% | +$8.12K |
|
1093
Allogene Therapeutics
ALLO
$246M
| $38.4K | ﹤0.01% |
34,000
-151,646
| -82% | -$171K |
|
1094
AdvisorShares Pure US Cannabis ETF
MSOS
$853M
| $37.4K | ﹤0.01% |
15,500
| – | – |
|
1095
Terns Pharmaceuticals
TERN
$640M
| $37.3K | ﹤0.01% |
10,000
-4,000
| -29% | -$14.9K |
|
1096
Aclaris Therapeutics
ACRS
$221M
| $36.9K | ﹤0.01% |
26,000
+4,000
| +18% | +$5.68K |
|
1097
Sutro Biopharma
STRO
$84M
| $35.7K | ﹤0.01% |
50,000
| – | – |
|
1098
Pulmonx
LUNG
$67.6M
| $31.4K | ﹤0.01% |
12,116
| – | – |
|
|
CRON
1099
Cronos Group
CRON
$957M
| $26.9K | ﹤0.01% |
14,000
| – | – |
|
1100
ImmunityBio
IBRX
$2.22B
| $26.4K | ﹤0.01% |
10,000
-6,000
| -38% | -$15.8K |
|